A detailed history of Boothbay Fund Management, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 116,854 shares of BVS stock, worth $858,876. This represents 0.01% of its overall portfolio holdings.

Number of Shares
116,854
Previous 83,737 39.55%
Holding current value
$858,876
Previous $554,000 40.97%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.14 - $7.64 $203,338 - $253,013
33,117 Added 39.55%
116,854 $781,000
Q2 2025

Aug 14, 2025

BUY
$6.2 - $9.51 $519,169 - $796,338
83,737 New
83,737 $554,000
Q3 2024

Nov 14, 2024

BUY
$5.73 - $11.95 $93,439 - $194,868
16,307 Added 11.65%
156,307 $1.87 Million
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $554,400 - $970,200
140,000 New
140,000 $805,000
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $41,092 - $75,929
14,219 New
14,219 $74,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $453M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.